| 國立成功大學 |
2023 |
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
|
Sequist, L.V.;Yang, J.C.-H.;Yamamoto, N.;O'Byrne, K.;Hirsh, V.;Mok, T.;Geater, S.L.;Orlov, S.;Tsai, C.-M.;Boyer, M.;Su, W.-C.;Bennouna, J.;Kato, T.;Gorbunova, V.;Lee, K.H.;Shah, R.;Massey, D.;Zazulina, V.;Shahidi, M.;Schuler, M. |
| 臺大學術典藏 |
2022-09-15T01:08:58Z |
A phase 1 study of oral ASP5878, a selective small-molecule inhibitor of fibroblast growth factor receptors 1–4, as a single dose and multiple doses in patients with solid malignancies
|
Yamamoto N.; Ryoo B.-Y.; Keam B.; Kudo M.; Chia-Chi Lin; Kunieda F.; Ball H.A.; Moran D.; Komatsu K.; Takeda K.; Fukuda M.; Furuse J.; Morita S.; Doi T. |
| 臺大學術典藏 |
2022-09-15T01:08:48Z |
Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia—Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium
|
Shimizu T.; Kim D.-W.; Loong H.H.; Chia-Chi Lin; Ng M.C.H.; Yamamoto N.; Ma B.; Tan D.S.W. |
| 臺大學術典藏 |
2022-09-15T01:08:46Z |
Pharmacokinetics, safety, and efficacy of trastuzumab deruxtecan with concomitant ritonavir or itraconazole in patients with HER2-expressing advanced solid tumors
|
Takahashi S.; Karayama M.; Takahashi M.; Watanabe J.; Minami H.; Yamamoto N.; Kinoshita I.; Chia-Chi Lin; Im Y.-H.; Achiwa I.; Kamiyama E.; Okuda Y.; Lee C.; Bang Y.-J. |
| 臺大學術典藏 |
2022-08-10T02:37:41Z |
EGFR tyrosine kinase inhibitors for EGFR mutation-positive non-small-cell lung cancer: Outcomes in Asian populations
|
Kim E.S.; Melosky B.; Park K.; Yamamoto N.; CHIH-HSIN YANG |
| 臺大學術典藏 |
2022-08-10T02:37:41Z |
Efficacy and Safety of S-1 Compared With Docetaxel in Elderly Patients With Advanced NSCLC Previously Treated With Platinum-Based Chemotherapy: A Subgroup Analysis of the EAST-LC Trial
|
CHIH-HSIN YANG; Mok T.S.K.; Lu S.; Nakagawa K.; Yamamoto N.; Shi Y.-K.; Zhang L.; Soo R.A.; Morita S.; Tamura T. |
| 臺大學術典藏 |
2022-06-27T07:01:36Z |
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: A combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
|
Yang J.C.-H.; Sequist L.V.; Geater S.L.; Tsai C.-M.; Mok T.S.K.; Schuler M.; Yamamoto N.; CHONG-JEN YU; Ou S.H.I.; Zhou C.; Massey D.; Zazulina V.; Wu Y.-L. |
| 臺大學術典藏 |
2022-03-15T05:39:22Z |
The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma
|
Heng M.; Gupta A.; Chung P.W.; Healey J.H.; Vaynrub M.; Rose P.S.; Houdek M.T.; Lin P.P.; Bishop A.J.; Hornicek F.J.; Chen Y.-L.; Lozano-Calderon S.; Holt G.E.; Han I.; Biau D.; Niu X.; Bernthal N.M.; Ferguson P.C.; Wunder J.S.; Ueda T.; Kakunaga S.; Kawai A.; Sugiura H.; Kidani T.; Kunisasa T.; Ozaki T.; Ae K.; Nagano A.; Ohno T.; Hiraoka K.; Yamamoto N.; Tsuchiya H.; Matsumoto Y.; Yanagawa T.; Nakayama R.; Morioka H.; Kubo T.; Simose S.; Yamagami Y.; Yamamoto T.; Kawasaki M.; Torigoe T.; Yazawa Y.; Akiyama T.; Gokita T.; Manabe J.; Kaya M.; Emori M.; Nakamura T.; Matsumine A.; Sugihara S.; Yokouchi M.; Komiya S.; Suehara Y.; Takagi T.; Kawamoto T.; Wasa J.; Yonemoto T.; Ishii T.; Baba I.; Hoshi M.; Hamada K.; Naka N.; Sotobori T.; Araki N.; Okuma T.; Goto T.; Kobayashi H.; Kawano H.; Hosaka M.; Futani H.; Hiraga H.; Nishida Y.; Griffin A.; Razak A.R.A.; Shultz D.B.; Catton C.; Robinson S.; Patel S.R.; Lewis V.O.; Guadagnolo B.A.; DeLaney T.; Wang H.; Raskin K.; Callan A.K.; Henshaw R.; Isler M.; Mottard S.; Chen W.-M.; Traub F.; WEI-WU CHEN; Turcotte R.E.; Davidson D.; Tunn P.-U.; Loong H.; Ghert M.; Werier J.; Clarkson P.; Abraham J.A.; Japanese Musculoskeletal Oncology Group (JMOG), Soft Tissue Osteosarcoma International Collaborative (STOIC) |
| 臺大學術典藏 |
2022 |
Tolerability and efficacy of durvalumab, either as monotherapy or in combination with tremelimumab, in patients from Asia with advanced biliary tract, esophageal, or head-and-neck cancer
|
Doki Y.; Ueno M.; CHIH-HUNG HSU; Oh D.-Y.; Park K.; Yamamoto N.; Ioka T.; Hara H.; Hayama M.; Nii M.; Komuro K.; Sugimoto M.; Tahara M. |
| 國立成功大學 |
2022 |
Final Overall Survival, Safety, and Quality of Life Results From a Phase 2 Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced NSCLC
|
Wu, Y.-L.;Lu, S.;Yang, J.C.-H.;Zhou, J.;Seto, T.;Ahn, M.-J.;Su, W.-C.;Yamamoto, N.;Kim, D.-W.;Paolini, J.;Usari, T.;Iadeluca, L.;Wilner, K.D.;Goto, K. |
| 臺大學術典藏 |
2021-11-03T02:32:59Z |
RELAY subgroup analyses by EGFR Ex19del and Ex21L858R mutations for ramucirumab plus erlotinib in metastatic non?small cell lung cancer
|
Nakagawa K.; Nadal E.; Garon E.B.; Nishio M.; Seto T.; Yamamoto N.; Park K.; JIN-YUAN SHIH; Paz-Ares L.; Frimodt-Moller B.; Zimmermann A.H.; Wijayawardana S.; Visseren-Grul C.; Reck M. |
| 臺大學術典藏 |
2021-09-23T03:35:34Z |
Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
|
Nogueira R.G.; Qureshi M.M.; Abdalkader M.; Martins S.O.; Yamagami H.; Qiu Z.; Mansour O.Y.; Sathya A.; Czlonkowska A.; Tsivgoulis G.; Aguiar de Sousa D.; Demeestere J.; Mikulik R.; Vanacker P.; Siegler J.E.; K?rv J.; Biller J.; Liang C.W.; Sangha N.S.; Zha A.M.; Czap A.L.; Holmstedt C.A.; Turan T.N.; Ntaios G.; Malhotra K.; Tayal A.; Loochtan A.; Ranta A.; Mistry E.A.; Alexandrov A.W.; Huang D.Y.; Yaghi S.; Raz E.; Sheth S.A.; Mohammaden M.H.; Frankel M.; Bila Lamou E.G.; Aref H.M.; Elbassiouny A.; Hassan F.; Menecie T.; Mustafa W.; Shokri H.M.; Roushdy T.; Sarfo F.S.; Alabi T.O.; Arabambi B.; Nwazor E.O.; Sunmonu T.A.; Wahab K.; Yaria J.; Mohammed H.H.; Adebayo P.B.; Riahi A.D.; Sassi S.B.; Gwaunza L.; Ngwende G.W.; Sahakyan D.; Rahman A.; Ai Z.; Bai F.; Duan Z.; Hao Y.; Huang W.; Li G.; Li W.; Liu G.; Luo J.; Shang X.; Sui Y.; Tian L.; Wen H.; Wu B.; Yan Y.; Yuan Z.; Zhang H.; Zhang J.; Zhao W.; Zi W.; Leung T.W.; Chugh C.; Huded V.; Menon B.; Pandian J.D.; Sylaja P.N.; Usman F.S.; Farhoudi M.; Hokmabadi E.S.; Horev A.; Reznik A.; Sivan Hoffmann R.; Ohara N.; Sakai N.; Watanabe D.; Yamamoto R.; Doijiri R.; Tokuda N.; Yamada T.; Terasaki T.; Yazawa Y.; Uwatoko T.; Dembo T.; Shimizu H.; Sugiura Y.; Miyashita F.; Fukuda H.; Miyake K.; Shimbo J.; Sugimura Y.; Yagita Y.; Takenobu Y.; Matsumaru Y.; Yamada S.; Kono R.; Kanamaru T.; Yamazaki H.; Sakaguchi M.; Todo K.; Yamamoto N.; Sonoda K.; Yoshida T.; Hashimoto H.; Nakahara I.; Kondybayeva A.; Faizullina K.; Kamenova S.; Zhanuzakov M.; Baek J.-H.; Hwang Y.; Lee J.S.; Lee S.B.; Moon J.; Park H.; Seo J.H.; Seo K.-D.; Sohn S.I.; Young C.J.; Ahdab R.; Wan Zaidi W.A.; Aziz Z.A.; Basri H.B.; Chung L.W.; Ibrahim A.B.; Ibrahim K.A.; Looi I.; Tan W.Y.; Yahya N.W.; Groppa S.; Leahu P.; Al Hashmi A.M.; Imam Y.Z.; Akhtar N.; Pineda-Franks M.C.; Co C.O.; Kandyba D.; Alhazzani A.; Al-Jehani H.; Tham C.H.; Mamauag M.J.; Venketasubramanian N.; Chen C.-H.; SUNG-CHUN TANG; Churojana A.; Akil E.; Ayka? ?.; Ozdemir A.O.; Giray S.; Hussain S.I.; John S.; Le Vu H.; Tran A.D.; Nguyen H.H.; Nhu Pham T.; Nguyen T.H.; Nguyen T.Q.; Gattringer T.; Enzinger C.; Killer-Oberpfalzer M.; Bellante F.; De Blauwe S.; Vanhooren G.; De Raedt S.; Dusart A.; Lemmens R.; Ligot N.; Pierre Rutgers M.; Yperzeele L.; Alexiev F.; Sakelarova T.; Bedekovi? M.R.; Budincevic H.; Cindric I.; Hucika Z.; Ozretic D.; Saric M.S.; Pfeifer F.; Karpowic I.; Cernik D.; Sramek M.; Skoda M.; Hlavacova H.; Klecka L.; Koutny M.; Vaclavik D.; Skoda O.; Fiksa J.; Hanelova K.; Nevsimalova M.; Rezek R.; Prochazka P.; Krejstova G.; Neumann J.; Vachova M.; Brzezanski H.; Hlinovsky D.; Tenora D.; Jura R.; Jur?k L.; Novak J.; Novak A.; Topinka Z.; Fibrich P.; Sobolova H.; Volny O.; Krarup Christensen H.; Drenck N.; Klingenberg Iversen H.; Simonsen C.Z.; Truelsen T.C.; Wienecke T.; Vibo R.; Gross-Paju K.; Toomsoo T.; Antsov K.; Caparros F.; Cordonnier C.; Dan M.; Faucheux J.-M.; Mechtouff L.; Eker O.; Lesaine E.; Ondze B.; Peres R.; Pico F.; Piotin M.; Pop R.; Rouanet F.; Gubeladze T.; Khinikadze M.; Lobjanidze N.; Tsiskaridze A.; Nagel S.; Ringleb P.A.; Rosenkranz M.; Schmidt H.; Sedghi A.; Siepmann T.; Szabo K.; Thomalla G.; Palaiodimou L.; Sagris D.; Kargiotis O.; Klivenyi P.; Szapary L.; Tarkanyi G.; Adami A.; Bandini F.; Calabresi P.; Frisullo G.; Renieri L.; Sangalli D.; Pirson A.; Uyttenboogaart M.; van den Wijngaard I.; Kristoffersen E.S.; Brola W.; Fudala M.; Horoch-Lyszczarek E.; Karlinski M.; Kazmierski R.; Kram P.; Rogoziewicz M.; Kaczorowski R.; Luchowski P.; Sienkiewicz-Jarosz H.; Sobolewski P.; Fryze W.; Wisniewska A.; Wiszniewska M.; Ferreira P.; Ferreira P.; Fonseca L.; Marto J.P.; Pinho E Melo T.; Nunes A.P.; Rodrigues M.; Tedim Cruz V.; Falup-Pecurariu C.; Krastev G.; Mako M.; de Leci?ana M.A.; Arenillas J.F.; Ayo-Martin O.; Cruz Culebras A.; Tejedor E.D.; Montaner J.; P?rez-S?nchez S.; Tola Arribas M.A.; Rodriguez Vasquez A.; Mayza M.; Bernava G.; Brehm A.; Machi P.; Fischer U.; Gralla J.; Michel P.L.; Psychogios M.-N.; Strambo D.; Banerjee S.; Krishnan K.; Kwan J.; Butt A.; Catanese L.; Demchuk A.M.; Field T.; Haynes J.; Hill M.D.; Khosravani H.; Mackey A.; Pikula A.; Saposnik G.; Scott C.A.; Shoamanesh A.; Shuaib A.; Yip S.; Barboza M.A.; Barrientos J.D.; Portillo Rivera L.I.; Gongora-Rivera F.; Novarro-Escudero N.; Blanco A.; Abraham M.; Alsbrook D.; Altschul D.; Alvarado-Ortiz A.J.; Bach I.; Badruddin A.; Barazangi N.; Brereton C.; Castonguay A.; Chaturvedi S.; Chaudry S.A.; Choe H.; Choi J.H.; Dharmadhikari S.; Desai K.; Devlin T.G.; Doss V.T.; Edgell R.; Etherton M.; Farooqui M.; Frei D.; Gandhi D.; Grigoryan M.; Gupta R.; Hassan A.E.; Helenius J.; Kaliaev A.; Kaushal R.; Khandelwal P.; Khawaja A.M.; Khoury N.N.; Kim B.S.; Kleindorfer D.O.; Koyfman F.; Lee V.H.; Leung L.Y.; Linares G.; Linfante I.; Lutsep H.L.; Macdougall L.; Male S.; Malik A.M.; Masoud H.; McDermott M.; Mehta B.P.; Min J.; Mittal M.; Morris J.G.; Multani S.S.; Nahab F.; Nalleballe K.; Nguyen C.B.; Novakovic-White R.; Ortega-Gutierrez S.; Rahangdale R.H.; Ramakrishnan P.; Romero J.R.; Rost N.; Rothstein A.; Ruland S.; Shah R.; Sharma M.; Silver B.; Simmons M.; Singh A.; Starosciak A.K.; Strasser S.L.; Szeder V.; Teleb M.; Tsai J.P.; Voetsch B.; Balaguera O.; Pujol Lereis V.A.; Luraschi A.; Almeida M.S.; Cardoso F.B.; Conforto A.; De Deus Silva L.; Varrone Giacomini L.; Oliveira Lima F.; Longo A.L.; Magalh?es P.S.C.; Martins R.T.; Mont'alverne F.; Mora Cuervo D.L.; Costa Rebello L.; Valler L.; Zetola V.F.; Lavados P.M.; Navia V.; Olavarr?a V.V.; Almeida Toro J.M.; Amaya P.F.R.; Bayona H.; Corredor A.; Rivera Ordonez C.E.; Mantilla Barbosa D.K.; Lara O.; Pati?o M.R.; Diaz Escobar L.F.; Dejesus Melgarejo Fari?a D.E.; Cardozo Villamayor A.; Zelaya Zarza A.J.; Barrientos Iman D.M.; Rodriguez Kadota L.; Campbell B.; Hankey G.J.; Hair C.; Kleinig T.; Ma A.; Tomazini Martins R.; Sahathevan R.; Thijs V.; Salazar D.; Yuan-Hao Wu T.; Haussen D.C.; Liebeskind D.; Yavagal D.R.; Jovin T.G.; Zaidat O.O.; Nguyen T.N.; SVIN COVID-19 Global Stroke Registry, SVIN COVID-19 Global Stroke Registry |
| 臺大學術典藏 |
2021-07-03T03:35:22Z |
The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice
|
Okada M.; Takemoto Y.; Okuno Y.; Hashimoto S.; Yoshida S.; Fukunaga Y.; Tanaka T.; Kita Y.; Kuwayama S.; Muraki Y.; Kanamaru N.; Takai H.; Okada C.; Sakaguchi Y.; Furukawa I.; Yamada K.; Matsumoto M.; Kase T.; Demello D.E.; Peiris J.S.M.; PEI-JER CHEN; Yamamoto N.; Yoshinaka Y.; Nomura T.; Ishida I.; Morikawa S.; Tashiro M.; Sakatani M. |
| 臺大學術典藏 |
2021-07-03T03:35:16Z |
Development of vaccines and passive immunotherapy against SARS coronavirus using mouse and SCID-PBL/hu mouse models
|
Okada M.; Takemoto Y.; Okuno Y.; Hashimoto S.; Fukunaga Y.; Tanaka T.; Kita Y.; Kuwayama S.; Muraki Y.; Kanamaru N.; Takai H.; Okada C.; Sakaguchi Y.; Furukawa I.; Yamada K.; Izumiya M.; Yoshida S.; Matsumoto M.; Kase T.; Peiris J.S.M.; DeMello D.E.; PEI-JER CHEN; Yamamoto N.; Yoshinaka Y.; Nomura T.; Ishida I.; Morikawa S.; Tashiro M.; Sakatani M. |
| 臺大學術典藏 |
2021-07-03T03:35:06Z |
Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models
|
Okada M.; Okuno Y.; Hashimoto S.; Kita Y.; Kanamaru N.; Nishida Y.; Tsunai Y.; Inoue R.; Nakatani H.; Fukamizu R.; Namie Y.; Yamada J.; Takao K.; Asai R.; Asaki R.; Kase T.; Takemoto Y.; Yoshida S.; Peiris J.S.M.; PEI-JER CHEN; Yamamoto N.; Nomura T.; Ishida I.; Morikawa S.; Tashiro M.; Sakatani M. |
| 臺大學術典藏 |
2021-03-18T03:23:31Z |
The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma
|
Heng M.; Gupta A.; Chung P.W.; Healey J.H.; Vaynrub M.; Rose P.S.; Houdek M.T.; Lin P.P.; Bishop A.J.; Hornicek F.J.; Chen Y.-L.; Lozano-Calderon S.; Holt G.E.; Han I.; Biau D.; Niu X.; Bernthal N.M.; Ferguson P.C.; Wunder J.S.; Ueda T.; Kakunaga S.; Kawai A.; Sugiura H.; Kidani T.; Kunisasa T.; Ozaki T.; Ae K.; Nagano A.; Ohno T.; Hiraoka K.; Yamamoto N.; Tsuchiya H.; Matsumoto Y.; Yanagawa T.; Nakayama R.; Morioka H.; Kubo T.; Simose S.; Yamagami Y.; Yamamoto T.; Kawasaki M.; Torigoe T.; Yazawa Y.; Akiyama T.; Gokita T.; Manabe J.; Kaya M.; Emori M.; Nakamura T.; Matsumine A.; Sugihara S.; Yokouchi M.; Komiya S.; Suehara Y.; Takagi T.; Kawamoto T.; Wasa J.; Yonemoto T.; Ishii T.; Baba I.; Hoshi M.; Hamada K.; Naka N.; Sotobori T.; Araki N.; Okuma T.; Goto T.; Kobayashi H.; Kawano H.; Hosaka M.; Futani H.; Hiraga H.; Nishida Y.; Griffin A.; Razak A.R.A.; Shultz D.B.; Catton C.; Robinson S.; Patel S.R.; Lewis V.O.; Guadagnolo B.A.; DeLaney T.; Wang H.; Raskin K.; Callan A.K.; Henshaw R.; Isler M.; Mottard S.; Chen W.-M.; Traub F.; WEI-WU CHEN; Turcotte R.E.; Davidson D.; Tunn P.-U.; Loong H.; Ghert M.; Werier J.; Clarkson P.; Abraham J.A.; Japanese Musculoskeletal Oncology Group (JMOG), Soft Tissue Osteosarcoma International Collaborative (STOIC) |
| 臺大學術典藏 |
2021-01-15T03:46:37Z |
Asian consensus statements on endoscopic management of walled-off necrosis. Part 2: Endoscopic management
|
Isayama H.; Nakai Y.; Rerknimitr R.; Khor C.; Lau J.; HSIU-PO WANG; Seo D.W.; Ratanachu-ek T.; Lakhtakia S.; Ang T.L.; Ryozawa S.; Hayashi T.; Kawakami H.; Yamamoto N.; Iwashita T.; Itokawa F.; Kuwatani M.; Kitano M.; Hanada K.; Kogure H.; Hamada T.; Ponnudurai R.; Moon J.H.; Itoi T.; Yasuda I.; Irisawa A.; Maetani I. |
| 臺大學術典藏 |
2021-01-15T03:46:37Z |
Asian consensus statements on endoscopic management of walled-off necrosis Part 1: Epidemiology, diagnosis, and treatment
|
Isayama H.; Nakai Y.; Rerknimitr R.; Khor C.; Lau J.; HSIU-PO WANG; Seo D.W.; Ratanachu-ek T.; Lakhtakia S.; Ang T.L.; Ryozawa S.; Hayashi T.; Kawakami H.; Yamamoto N.; Iwashita T.; Itokawa F.; Kuwatani M.; Kitano M.; Hanada K.; Kogure H.; Hamada T.; Ponnudurai R.; Moon J.H.; Itoi T.; Yasuda I.; Irisawa A.; Maetani I. |
| 臺大學術典藏 |
2020-05-26T09:27:01Z |
Symptom control and quality of life in lux-lung 3: A phase III study of afatinib or cisplatin/pemetrexed in patients with advanced lung adenocarcinoma with EGFR mutations
|
Chih-Hsin Yang;Hirsh V;Schuler M;Yamamoto N;O'Byrne K.J;Mok T.S.K;Zazulina V;Shahidi M;Lungershausen J;Massey D;Palmer M;Sequist L.V.; CHIH-HSIN YANG; Hirsh V; Schuler M; Yamamoto N; O'Byrne K.J; Mok T.S.K; Zazulina V; Shahidi M; Lungershausen J; Massey D; Palmer M; Sequist L.V. |
| 臺大學術典藏 |
2020-05-26T09:27:01Z |
Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations
|
Sequist L.V;Chih-Hsin Yang;Yamamoto N;O'Byrne K;Hirsh V;Mok T;Geater S.L;Orlov S;Tsai C.-M;Boyer M;Su W.-C;Bennouna J;Kato T;Gorbunova V;Lee K.H;Shah R;Massey D;Zazulina V;Shahidi M;Schuler M.; Sequist L.V; CHIH-HSIN YANG; Yamamoto N; O'Byrne K; Hirsh V; Mok T; Geater S.L; Orlov S; Tsai C.-M; Boyer M; Su W.-C; Bennouna J; Kato T; Gorbunova V; Lee K.H; Shah R; Massey D; Zazulina V; Shahidi M; Schuler M. |
| 臺大學術典藏 |
2020-05-26T09:26:57Z |
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: A combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
|
CHIH-HSIN YANG; Sequist L.V; Geater S.L; Tsai C.-M; Mok T.S.K; Schuler M; Yamamoto N; Yu C.-J; Ou S.H.I; Zhou C; Massey D; Zazulina V; Wu Y.-L.; Wu Y.-L.;Zazulina V;Massey D;Zhou C;Ou S.H.I;Yu C.-J;Yamamoto N;Schuler M;Mok T.S.K;Tsai C.-M;Geater S.L;Sequist L.V;Chih-Hsin Yang |
| 臺大學術典藏 |
2020-05-26T09:26:54Z |
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): Analysis of overall survival data from two randomised, phase 3 trials
|
Sequist L.V.;Zazulina V;Shahidi M;Massey D;Kato T;Lee K.H;Su W.-C;Boyer M;Mok T;Orlov S;Bennouna J;Hirsh V;Gorbunova V;Tsai C.-M;Lee K.Y;Geater S.L;Huang Y;Lu S;Feng J;O'Byrne K;Hu C.-P;Zhou C;Yamamoto N;Popat S;Sebastian M;Schuler M;Wu Y.-L;Chih-Hsin Yang; CHIH-HSIN YANG; Wu Y.-L; Schuler M; Sebastian M; Popat S; Yamamoto N; Zhou C; Hu C.-P; O'Byrne K; Feng J; Lu S; Huang Y; Geater S.L; Lee K.Y; Tsai C.-M; Gorbunova V; Hirsh V; Bennouna J; Orlov S; Mok T; Boyer M; Su W.-C; Lee K.H; Kato T; Massey D; Shahidi M; Zazulina V; Sequist L.V. |
| 臺大學術典藏 |
2020-05-26T09:26:51Z |
Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma: Post hoc analyses of the randomized LUX-Lung 3 and 6 trials
|
Shah R; Märten A; Massey D; Wind S; Wu Y.-L.; Dickgreber N; Okamoto I; Sebastian M; Huang Y; Hirsh V; Lu S; O'Byrne K; Feng J; Wu Y.-L.;Wind S;Massey D;M?rten A;Shah R;Dickgreber N;Okamoto I;Sebastian M;Huang Y;Hirsh V;Lu S;O'Byrne K;Feng J;Yamamoto N;Hu C.-P;Mok T;Geater S.L;Schuler M;Zhou C;Sequist L.V;Chih-Hsin Yang; CHIH-HSIN YANG; Sequist L.V; Zhou C; Schuler M; Geater S.L; Mok T; Hu C.-P; Yamamoto N |
| 臺大學術典藏 |
2020-05-26T09:26:48Z |
First-line afatinib versus chemotherapy in patients with non-small cell lung cancer and common epidermal growth factor receptor gene mutations and brain metastases
|
Chih-Hsin Yang;Zazulina V;Massey D;Sequist L.V;Popat S;Mok T;Yamamoto N;O'Byrne K;Hirsh V;Wu Y.-L;Schuler M; Schuler M; Wu Y.-L; Hirsh V; O'Byrne K; Yamamoto N; Mok T; Popat S; Sequist L.V; Massey D; Zazulina V; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-26T09:26:46Z |
138PD: Impact of dose adjustment on the safety and efficacy of afatinib in patients (pts) with advanced EGFR mutation-positive non-small cell lung cancer (NSCLC): Post-hoc analyses of LUX-Lung 3 (LL3) and LUX-Lung 6 (LL6)
|
Wu Y.-L.;Shah R;Mok T;Hirsh V;O'Byrne K;Zhou C;Yamamoto N;Sequist L.V;Chih-Hsin Yang;Schuler M; Schuler M; CHIH-HSIN YANG; Sequist L.V; Yamamoto N; Zhou C; O'Byrne K; Hirsh V; Mok T; Shah R; Wu Y.-L. |
